L. Edwards
Fortuna: 2 M $ al 31/07/2026
Fortuna: 2 M $ al 31/07/2026
Mr. L.
T.
Edwards is a Chief Commercial Officer & Executive VP at Arcutis Biotherapeutics, Inc. Mr. Edwards was previously employed as a Vice President & Head-Immunology Business by Incyte Corp.
and a Vice President-Immunology by UCB, Inc. He received his undergraduate degree from East Tennessee State University and an MBA from Embry-Riddle Aeronautical University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 08/04/2026 | 59.928 ( 0,05 % ) | 2 M $ | 31/07/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 21/08/2026 |
| INCYTE CORPORATION | Corporate Officer/Principal | - |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
East Tennessee State University
East Tennessee State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Embry-Riddle Aeronautical University
Embry-Riddle Aeronautical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Provides financial services | Finance |
Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.